Insights from Pim1 structure for anti-cancer drug design

Author： Ogawa Naoko   Yuki Hitomi   Tanaka Akiko  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.12, 2012-12, pp. : 1177-1192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using Insights into Pim1 Structure to Design New Anticancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3964-3978

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

By  

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 213-222

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A.   Ackland1 S.P.   Gardiner E.   Walkom C.C.   Sakoff1 J.A.  

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 22, 2005-08 ,pp. : 2841-2854

Bentham Science Publishers

Access to resources Recommend Favorite